| 2024 | Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer: Updated Overall Survival Outcomes From Phase III PRODIGY | JOURNAL OF CLINICAL ONCOLOGY |
| 2024 | Prognostic Significance of ARID1A Expression Patterns Varies with Molecular Subtype in Advanced Gastric Cancer
| GUT AND LIVER |
| 2024 | Prognostic and predictive impact of sex in locally advanced microsatellite instability high gastric or gastroesophageal junction cancer: An individual patient data pooled analysis of randomized clinical trials | EUROPEAN JOURNAL OF CANCER |
| 2024 | A randomized controlled study to assess the effect of mosapride citrate on intestinal recovery following gastrectomy
| SCIENTIFIC REPORTS |
| 2023 | Clinical molecular subtyping reveals intrinsic mesenchymal reprogramming in gastric cancer cells
| EXPERIMENTAL AND MOLECULAR MEDICINE |
| 2023 | PMCA inhibition reverses drug resistance in clinically refractory cancer patient-derived models
| BMC MEDICINE |
| 2022 | Determinants of clinical outcomes of gastric cancer patients treated with neoadjuvant chemotherapy: a sub-analysis of the PRODIGY study | GASTRIC CANCER |
| 2022 | SFRP4 and CDX1 Are Predictive Genes for Extragastric Recurrence of Early Gastric Cancer after Curative Resection
| JOURNAL OF CLINICAL MEDICINE |
| 2022 | International Retrospective Cohort Study of Conversion Therapy for Stage IV Gastric Cancer 1 (CONVO-GC-1)
| ANNALS OF GASTROENTEROLOGICAL SURGERY |
| 2022 | Development and validation of a prognostic and predictive 32-gene signature for gastric cancer
| NATURE COMMUNICATIONS |
| 2022 | Radiological criteria for selecting candidates for neoadjuvant chemotherapy for gastric cancer: an exploratory analysis from the PRODIGY study | GASTRIC CANCER |
| 2021 | Microsatellite Instability and Effectiveness of Adjuvant Treatment in pT1N1 Gastric Cancer: A Multicohort Study | ANNALS OF SURGICAL ONCOLOGY |
| 2021 | Single patient classifier as a prognostic biomarker in pT1N1 gastric cancer: Results from two large Korean cohorts
| CHINESE JOURNAL OF CANCER RESEARCH |
| 2021 | Serum glucose excretion after Roux-en-Y gastric bypass: a potential target for diabetes treatment | GUT |
| 2021 | PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer | JOURNAL OF CLINICAL ONCOLOGY |
| 2021 | Daytime Glycemic Variability and Frailty in Older Patients with Diabetes: a Pilot Study Using Continuous Glucose Monitoring
| JOURNAL OF KOREAN MEDICAL SCIENCE |
| 2021 | Prevalence of cancer susceptibility variants in patients with multiple Lynch syndrome related cancers
| SCIENTIFIC REPORTS |
| 2021 | Detection of asymptomatic recurrence improves survival of gastric cancer patients
| CANCER MEDICINE |
| 2021 | The Impact of Nerve Involvement on the Prognosis of Gastric Cancer Patients with Curative Gastrectomy: An International Multicenter Analysis
| DISEASE MARKERS |
| 2021 | The Effectiveness of Postoperative Chemotherapy on pT1bN0 and pT2N0 Gastric Cancer Patients with Risk Factors: An International Dual-Center Analysis
| YONSEI MEDICAL JOURNAL |
| 2021 | Clinicopathologic Features of Submucosal Papillary Gastric Cancer Differ from Those of Other Differentiated-Type Histologies
| GUT AND LIVER |
| 2020 | Effect of histologic differences between biopsy and final resection on treatment outcomes in early gastric cancer | SURGICAL ENDOSCOPY AND OTHER INTERVENTIONAL TECHNIQUES |
| 2020 | Reply to: "Stereotactic body radiation therapy vs. radiofrequency ablation for HCC: More questions than answers | JOURNAL OF HEPATOLOGY |
| 2020 | A Multi-cohort Study of the Prognostic Significance of Microsatellite Instability or Mismatch Repair Status after Recurrence of Resectable Gastric Cancer
| CANCER RESEARCH AND TREATMENT |
| 2020 | Chimeric Antigen Receptor T Cell Therapy Targeting ICAM-1 in Gastric Cancer
| MOLECULAR THERAPY-ONCOLYTICS |
| 2020 | Stratification of Postsurgical Computed Tomography Surveillance Based on the Extragastric Recurrence of Early Gastric Cancer | ANNALS OF SURGERY |
| 2020 | Comparison of Postoperative Nutritional Status after Distal Gastrectomy for Gastric Cancer Using Three Reconstructive Methods: a Multicenter Study of over 1300 Patients | JOURNAL OF GASTROINTESTINAL SURGERY |
| 2020 | Altered systematic glucose utilization after gastrectomy: correlation with weight loss | SURGERY FOR OBESITY AND RELATED DISEASES |
| 2020 | Contrasting Prognostic Effects of Tumor-Infiltrating Lymphocyte Density in Cardia and Non-cardia Gastric Adenocarcinomas
| JOURNAL OF GASTRIC CANCER |
| 2020 | The Suggestion of Revised Criteria for Endoscopic Resection of Differentiated-Type Submucosal Gastric Cancer | ANNALS OF SURGICAL ONCOLOGY |
| 2019 | Clinical Implications of Microsatellite Instability in Early Gastric Cancer
| JOURNAL OF GASTRIC CANCER |
| 2019 | The optimal timing of additional surgery after non-curative endoscopic resection to treat early gastric cancer: long-term follow-up study
| SCIENTIFIC REPORTS |
| 2019 | Multi-institutional validation of the 8th AJCC TNM staging system for gastric cancer: Analysis of survival data from high-volume Eastern centers and the SEER database | JOURNAL OF SURGICAL ONCOLOGY |
| 2019 | Prognostic Impact of Extended Lymph Node Dissection versus Limited Lymph Node Dissection on pN0 Proximal Advanced Gastric Cancer: a Propensity Score Matching Analysis
| JOURNAL OF GASTRIC CANCER |
| 2019 | Microsatellite Instability and Programmed Cell Death-Ligand 1 Expression in Stage II/III Gastric Cancer: Post Hoc Analysis of the CLASSIC Randomized Controlled study | ANNALS OF SURGERY |
| 2019 | Mismatch Repair Status of Gastric Cancer and Its Association with the Local and Systemic Immune Response | ONCOLOGIST |
| 2019 | A Lesion-Based Convolutional Neural Network Improves Endoscopic Detection and Depth Prediction of Early Gastric Cancer
| Journal of Clinical Medicine |
| 2019 | The incidence and risk factors for surgical site infection in older adults after gastric cancer surgery: A STROBE-compliant retrospective study
| Medicine |
| 2019 | Differences in the Efficacies of Pazopanib and Gemcitabine/Docetaxel as Second-Line Treatments for Metastatic Soft Tissue Sarcoma | Oncology |
| 2019 | Immunohistochemistry Biomarkers Predict Survival in Stage II/III Gastric Cancer Patients: From a Prospective Clinical Trial
| Cancer Research and Treatment |
| 2019 | Similar hematologic and nutritional outcomes after proximal gastrectomy with double-tract reconstruction in comparison to total gastrectomy for early upper gastric cancer | Surgical Endoscopy |
| 2019 | Phase II trial of preoperative sequential chemotherapy followed by chemoradiotherapy for high-risk gastric cancer | RADIOTHERAPY AND ONCOLOGY |
| 2019 | European validation of the Yonsei Gastric Cancer Prognosis Prediction Model after gastrectomy: Validation with the Netherlands Cancer Registry | EJSO |
| 2019 | Single Patient Classifier Assay, Microsatellite Instability, and Epstein-Barr Virus Status Predict Clinical Outcomes in Stage II/III Gastric Cancer: Results from CLASSIC Trial
| YONSEI MEDICAL JOURNAL |
| 2019 | A therapeutic strategy for chemotherapy-resistant gastric cancer via destabilization of both β-catenin and ras
| CANCERS |
| 2019 | A High Visceral-To-Subcutaneous Fat Ratio is an Independent Predictor of Surgical Site Infection after Gastrectomy
| JOURNAL OF CLINICAL MEDICINE |
| 2019 | The clinical implications of FDG-PET/CT differ according to histology in advanced gastric cancer.
| GASTRIC CANCER |
| 2019 | Role of probe-based confocal laser endomicroscopy-targeted biopsy in the molecular and histopathological study of gastric cancer | JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY |
| 2019 | S-1 Based Doublet as an Adjuvant Chemotherapy for Curatively Resected Stage III Gastric Cancer: Results from the Randomized Phase III POST Trial
| CANCER RESEARCH AND TREATMENT |
| 2019 | A case of gastric cancer metastasis to the breast in a female with BRCA2 germline mutation and literature review | ACTA CHIRURGICA BELGICA |
http://orcid.org/0000-0003-4386-6886
(7101653868)
